Contemporary Provider Management Practices and Attitudes Toward Referral for Advanced Heart Failure Therapies in Fontan Patients Across North America.
暂无分享,去创建一个
B. Marino | T. Alsaied | T. Karamlou | K. Schumacher | J. Gossett | Angira Patel | S. Amdani | S. Worley | Sara Sadat-Hossieny
[1] J. Kirklin,et al. Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients. , 2021, The Journal of thoracic and cardiovascular surgery.
[2] C. Ravishankar,et al. Fontan‐associated plastic bronchitis waitlist and heart transplant outcomes: A PHTS analysis , 2021, Pediatric transplantation.
[3] Y. D'udekem,et al. The Fontan outcomes network: first steps towards building a lifespan registry for individuals with Fontan circulation in the United States , 2020, Cardiology in the Young.
[4] B. McCrindle,et al. Results of the FUEL Trial , 2020, Circulation.
[5] C. VanderPluym,et al. Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[6] Richard Figliola,et al. Cavopulmonary assist: Long-term reversal of the Fontan paradox. , 2019, The Journal of thoracic and cardiovascular surgery.
[7] Sharon Chen,et al. Fontan-associated protein-losing enteropathy and post‒heart transplant outcomes: A multicenter study. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[8] K. Suresh,et al. Lung Circulation. , 2016, Comprehensive Physiology.
[9] Jack Rychik,et al. The Relentless Effects of the Fontan Paradox. , 2016, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.
[10] C. Canter,et al. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[11] J. Schaefer,et al. Collaborative Management of Chronic Illness , 1997, Annals of Internal Medicine.